ES2196348T3 - Composiciones para retardar el crecimiento del cabello y el uso correspondiente. - Google Patents

Composiciones para retardar el crecimiento del cabello y el uso correspondiente.

Info

Publication number
ES2196348T3
ES2196348T3 ES97932281T ES97932281T ES2196348T3 ES 2196348 T3 ES2196348 T3 ES 2196348T3 ES 97932281 T ES97932281 T ES 97932281T ES 97932281 T ES97932281 T ES 97932281T ES 2196348 T3 ES2196348 T3 ES 2196348T3
Authority
ES
Spain
Prior art keywords
compositions
hair growth
corresponding use
apoptosis
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97932281T
Other languages
English (en)
Inventor
Miri Seiberg
Stanley S Shapiro
Gerard F M J Cauwenbergh
Stephen J Wisniewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Companies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Consumer Companies LLC filed Critical Johnson and Johnson Consumer Companies LLC
Application granted granted Critical
Publication of ES2196348T3 publication Critical patent/ES2196348T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención utiliza proteasas de serina y su capacidad para inducir la muerte celular programada y la apoptosis en las papilas foliculares para modificar los cambios que se producen en el crecimiento capilar y la pigmentación capilar en los mamíferos. También se describen composiciones que tienen un agente con una parte de estructura similar a la de una parte de la molécula de tripsina, que permite a dicho agente inducir la muerte celular programada y apoptosis de la misma manera que la tripsina.
ES97932281T 1996-07-12 1997-06-25 Composiciones para retardar el crecimiento del cabello y el uso correspondiente. Expired - Lifetime ES2196348T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2162996P 1996-07-12 1996-07-12

Publications (1)

Publication Number Publication Date
ES2196348T3 true ES2196348T3 (es) 2003-12-16

Family

ID=21805280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97932281T Expired - Lifetime ES2196348T3 (es) 1996-07-12 1997-06-25 Composiciones para retardar el crecimiento del cabello y el uso correspondiente.

Country Status (16)

Country Link
EP (1) EP0996409B1 (es)
JP (1) JP2000515511A (es)
KR (1) KR20000023665A (es)
CN (1) CN1225575A (es)
AT (1) ATE238024T1 (es)
AU (1) AU722917B2 (es)
BR (1) BR9710303A (es)
CA (1) CA2260966A1 (es)
CZ (1) CZ7099A3 (es)
DE (1) DE69721329T2 (es)
DK (1) DK0996409T3 (es)
ES (1) ES2196348T3 (es)
IL (1) IL127806A0 (es)
PL (1) PL331082A1 (es)
PT (1) PT996409E (es)
WO (1) WO1998002134A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6020006A (en) * 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6121269A (en) * 1999-02-22 2000-09-19 Henry; James P. Reduction of hair growth
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US6375948B1 (en) * 1999-07-12 2002-04-23 Kao Corporation Treating method for suppressing hair growth
US6235737B1 (en) * 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
FR2826569A1 (fr) * 2001-06-28 2003-01-03 Oreal Utilisation topique de proteases ou d'extrait les contenant pour defriser les cheveux.
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US7261878B2 (en) 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US7160921B2 (en) 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US7015349B2 (en) 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
KR20060109902A (ko) * 2003-10-10 2006-10-23 코스메디칼 에이피에스 모발 성장 억제
EP1750736B1 (en) 2004-01-16 2010-04-21 Cognis France, S.A.S. Uses for the extract of gymnema sylvestris
CA2590328A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
ATE477786T1 (de) * 2005-05-23 2010-09-15 Reckitt Benckiser Uk Ltd Zusammensetzung enthalend wortmannin und ihre topische verwendung zur haarwuchshemmung
US7618956B2 (en) 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
JP2007217369A (ja) * 2006-02-17 2007-08-30 Trendy:Kk 除毛剤、除毛剤の製造方法、および除毛方法
US20080254055A1 (en) * 2007-04-11 2008-10-16 John Erich Oblong Compositions for Regulation of Hair Growth
DE102010015120B4 (de) 2010-04-16 2012-05-16 Sami Güleryüz Verwendung eines proteasehaltigen Haarwuchsreduktionsmittels
CN107648538A (zh) * 2017-10-11 2018-02-02 广州勇达生物科技有限公司 一种抑制体毛生长的中药组合物
KR20230004648A (ko) * 2020-04-15 2023-01-06 헨레즈 에이피에스 모낭-연관 병태를 치료하기 위한 조성물 및 방법
JP2022035899A (ja) * 2020-08-21 2022-03-04 均 石井 脱毛剤
CN114467858A (zh) * 2022-02-22 2022-05-13 中南大学湘雅医院 一种诱导白发模型的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879913A (ja) * 1981-11-09 1983-05-13 Taizo Ayukawa ヘアトニツク組成物
JPH05276939A (ja) * 1992-04-02 1993-10-26 Noevir Co Ltd ヒト毛細胞の培養方法並びに培地
WO1993025694A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology Inhibitors of ced-3 and related proteins
US5962301A (en) * 1992-06-12 1999-10-05 Massachusetts Institute Of Technology Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor

Also Published As

Publication number Publication date
CZ7099A3 (cs) 1999-09-15
JP2000515511A (ja) 2000-11-21
DE69721329T2 (de) 2004-02-12
EP0996409A1 (en) 2000-05-03
DE69721329D1 (de) 2003-05-28
IL127806A0 (en) 1999-10-28
EP0996409B1 (en) 2003-04-23
CN1225575A (zh) 1999-08-11
AU3577897A (en) 1998-02-09
KR20000023665A (ko) 2000-04-25
WO1998002134A1 (en) 1998-01-22
BR9710303A (pt) 1999-08-17
ATE238024T1 (de) 2003-05-15
CA2260966A1 (en) 1998-01-22
PT996409E (pt) 2003-08-29
PL331082A1 (en) 1999-06-21
DK0996409T3 (da) 2003-08-11
AU722917B2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
ES2196348T3 (es) Composiciones para retardar el crecimiento del cabello y el uso correspondiente.
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
ES2194106T3 (es) .ompuestos de imidazol
ATE500323T1 (de) Subtilisin-variante
PT758248E (pt) Formulacoes para o factor ix
BR0215405A (pt) Composições e processos de uso de collajolie
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
TR199902655A2 (xx) K�k�rt-fonksiyonel poliorganosiloksanlar
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ES2132644T3 (es) Metodo para reproducir in vitro la actividad proteolitica de la proteasa ns3 del virus de la hepatitis c (vhc).
NO20051968L (no) Peptidbasert balsam og fargestoffer for har, hud og negler.
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DK1255845T3 (da) Modificerede cytokiner til anvendelse i cancerterapi
ATE314084T1 (de) Kahalalid f formulierung
ES2084691T3 (es) Producto para la inhibicion de proteasas del vih.
ES2193197T3 (es) Craquizacion catalitica com mcm-49.
IT1252061B (it) Composizioni per uso dermatologico e cosmetico
ES2170971T3 (es) Uso de oligosacaridos para el refuerzo del poder edulcorante y para el mejoramiento del sabor de una mezcla de acesulfamo-k y aspartamo.
ES2191624T3 (es) Mezclas de tensioactivos usados como agentes humectantes y/o emulsionantes en preparaciones agroquimicas.
ATE302215T1 (de) Modulatoren von intrazellulären entzündungs-, zelltod- und zellüberlebenswegen, die card- und kinase-domänen enthalten
EP1529521A3 (de) Verwendung von hydrierten Sojaglyceriden in kosmetische Zubereitungen
ES2194744T3 (es) Derivados de quinocardina, su procedimiento de preparacion y su aplicacion como antifungicos.
BR0108187A (pt) Moléculas trade e usos relacionados com as mesmas